Changes in neocortex and striatum were char acterized over time following focal ischemia to the brain, Rats were subjected to permanent middle cerebral artery occlusion (MCA-O) and sacrificed 1, 3, 6, 12, or 24 h later. The affected tissue was processed for tetrazolium chloride (TTC) and cresyl violet staining, as well as for Western blots to detect calpain-induced spectrin proteol ysis. Significant changes in cell size and spectrin break down occurred within the first hour of occlusion, with further, dramatic changes in these two early markers con tinuing over time. Initial evidence of cell loss was noted at 1 h postocclusion in the striatum and at 3 h in the neocor tex. However, even in the center of the most affected portion of the neocortex, the majority of cells appeared to be intact through 6 h. By this time, a significant TTC-
The promise of using pharmaceutic means to re duce ischemic brain damage rests upon the knowl edge that the development of infarcted or necrotic tissue requires time as a pathologic cascade within the brain gradually progresses. In principle, this provides a so-called' 'therapeutic window of oppor tunity" for intervention (Choi, 1988; Meldrum, 1985; McCulloch et aI. , 1991) . However, if such a promise is to be realized, at least two key issues need to be clarified: (a) the duration of the thera peutic window (i. e. , At what point after an ischemic event occurs does significant, irreversible neuropa thology occur?) and (b) the identity of appropriate -------------_ ._-------defined infarct also emerged. These quantitative data in dicate that calpain-induced proteolysis occurs very soon after the ischemic insult, is correlated with earliest changes in cell hypotrophy, and precedes or occurs in tandem with evidence of significant cell loss. They also demonstrate that, while some cell loss occurs earlier than previously believed, the majority of cells remains mor phologically intact well beyond what is typically thought to be the window of opportunity for intervention. The results thus raise the question of how long after the isch emic event pharmaceutic intervention might be employed to salvage substantial numbers of neurons. Key Words: Calpain-Hypotrophy-Ischemia-Neurodegenera tion-Stroke-Therapeutic window.
targets for intervention (i. e. , Which of the many biochemical events associated with brain ischemia actually play a crucial role in the cell death that follows?) These two interrelated issues are ad dressed here.
Focal ischemia (as occurs with stroke) involves the severe reduction of blood flow to a localized area of the brain, typically through occlusion of a major artery for at least an hour. In contrast to the detailed information regarding the delayed neuronal death associated with transient global ischemia (as occurs with cardiac arrest) (Pulsinelli et aI. , 1982; Kirino et aI. , 1984) , the time required for substantial neuronal death following focal ischemia is much less clear. Indeed, there are as yet no published studies quantitating changes in cell number or size following focal ischemia.
While many earlier papers evaluated changes in infarct volume, they did not examine relatively early time points (i. e. , several hours postocclusion) and observed maximum infarction at the earliest time point measured (i. e. , 24 h or longer). Thus, they discounted the idea of a significant delay be tween ischemia and neuronal death (e. g. , Neder gaard, 1987; Nagasawa and Kogure, 1990; Nakano et al. , 1990; Chiamulera et al. , 1993 ; Clark et al. , 1993) . While a lack of substantial infarct within the first hours is mentioned in some reports, the obser vations were based on subjective impressions rather than quantitative data and statistical analyses (Osborne et al. , 1987; Persson et al. , 1989; Hakim et al. , 1992; Clark et al. , 1993) . More recently, insight into some of the temporal events associated with focal infarct has come from studies employing occlusions of different durations in conjunction with quantitative histology. CoUec tively, these papers suggest that while reliable cel lular changes occur within 30 min to 1 h of ischemia, they are not lethal (Knight et al. , 1991; Buchan et al. , 1992; Memezawa et al. , 1992; Minematsu et al. , 1992a,b) . This conclusion is based on the observa tion that reperfusion within a 1-to 2-h window al lowed sufficient cellular recovery to occur so that little or no infarct was observed at 24 h postocclu sion (Kaplan et al. , 1991; Memezawa et al. , 1992) . Thus, despite clear ischemia-induced changes noted during the first hour or two following middle cere bral artery occlusion (MCA-O), irreversible cell damage is believed to require longer periods of isch emia. However, as these conclusions are based upon infarct volume rather than quantitative changes in cell number or size, interpretative cau tion must be exercised.
It is also the case that the current literature does not provide insight into when irreversible cell dam age occurs. Several reperfusion studies argue that 3 h (but not 1 to 2 h) of MCA-O-induced ischemia leads to near-maximal cell death (Kaplan et al. , 1991; Buchan et al. , 1992; Memezawa et al. , 1992) . However, one cannot determine from the experi mental designs employed at what point in time sig nificant, irreversible cell damage actually occurred because none of the reperfusion studies examined tissue from anything less than end-stage, 24-h postocclusion tissue. It is conceivable, for example, that irreversible damage may not have occurred un til much later than 3 h but that simple reperfusion was not adequate to halt or reverse the natural pathogenesis initiated by a 3-h ischemic episode (which then became completely manifested by 24 h postocclusion). The key issue here is at what point in time large numbers of ceUs become atrophic, or otherwise suffer cumulative structure/function changes, so that pharmaceutic intervention can no longer affect the outcome. This question cannot be J Cereb Blood Flow Me/ab, Vol. 15, No, 6, 1995 addressed adequately by studying solely end-stage (i. e. , 24 h postocclusion) time points.
Insight into the above issue might be gained, however, by examining tissue at various time points following MCA-O to characterize and quantitate the changes that occur within the first several hours. This would provide a temporal description of the ischemic tissue as it proceeds from normal, to sub lethally injured, to necrotic states. To date, only two studies apparently have examined the progres sion of infarction following MCA-O in this manner. In one, a gradual increase in pannecrotic volume was reported, with continuing expansion occurring beyond 3 to 6 h post MCA-O (Buchan et al. , 1992) . No attempt was made to quantitate neuronal size or number. Another (Zhang et aI. , 1994) reported that the area of infarct continued to expand between 6 h (the minimum time point examined) and 12 h, at which point it reached asymptote. At this time, a shift was reported in the proportion of neurons ex hibiting "acute" signs of damage to those defined as "delayed" neuronal damage (possibly suggesting evidence of irreversible cell damage and loss?). However, it remains unclear when significant ceU lossj/rst occurs, exactly how severe it is over time, and how long it takes for complete ceU loss to evolve.
The second purpose of the current study is to address the issue of which of the many postisch emic biochemical events associated with focal isch emia may be cytotoxic to neurons. While clear agreement exists that high extraceUular glutamate and intracellular calcium levels precipitate ceU death (Siesjo, 1981; Rothman and Olney, 1986; Siesjo and Bengtsson, 1989; Zivin and Choi, 1991) , little agreement exists on what specific intraceUular event(s) plays a crucial cytotoxic role, per se. One potential pathogenic event that has generated re cent interest is the unregulated activation of calpain, an intraceUular protease that has been im plicated in a number of neuropathologic conditions (Seubert et al. , 1989; Siman and Noszek, 1988; Bar tus et al. , 1994a Bar tus et al. , ,b, 1995 . Calpain is activated by elevated levels of intraceUular calcium, causing pro teolysis of numerous neuronal cytoskeletal and reg ulatory proteins (MeUgren and Murachi, 1990) . It has thus been argued that the accumulation of nu merous, irreversible changes to these multiple sub strate proteins must eventually be lethal to the cell (Siman et al. , 1984; Lynch et al. , 1986; Seubert et aI. , 1987; Bartus, 1990; Bartus et al. , 1994a Bartus et al. , ,b, 1995 .
While recent studies have implicated calpain pro teolysis as a potential pathologic event in global ischemia (Seubert et al. , 1989; Lee et al. , 1991; Rob-erts-Lewis et aI. , 1994; Bartus et aI. , 1995) , no stud ies have yet directly examined the role of calpain activation via time-dependent substrate proteolysis in focal ischemia. Thus, calpain's role in stroke pathogenesis remains less clear.
The work reported here therefore had two inter related purposes: (a) to characterize and quantitate the nature and rate at which histologic changes oc cur following permanent MCA-O to help elucidate the therapeutic window and (b) to define the points in time when evidence of calpain activation ap pears, relative to neuromorphologic changes, thus further testing the hypothesis that calpain may play an important role in the neuropathology that follows focal brain ischemia.
METHODS

Animals and surgical procedure
Ninety male Sprague-Dawley rats (2S0-300 g) were used. Prior to surgery, the animals were housed in pairs with food and water available ad lib. At post surgery they were housed individually. The vivarium operated under a 12-h light/dark cycle and was maintained at a temperature of 72 ± 4°F. Following the initiation of permanent MCA-0, rats were sacrificed at one of the following time points:
Sections of forebrain were collected for either tetrazolium chloride (TTC)/spectrin or TTC/histological determina tions.
The MCA was permanently occluded, as Initially de scribed by Longa et al. (1989) under sodium pentobarbital anesthesia (70 mg/kg, i.p.). Briefly, this involves the ret rograde introduction of an intraluminal 3.0 nylon suture through the external carotid artery, into the internal ca rotid, and up to and through the circle of Willis, occluding the MCA that branches from the circle. This method re liably produces a large unilateral infarct at 24 h, involving both the neocortex and the striatum. The animals were allowed to awaken from anesthesia prior to returning to their home cage. In all cases, surgery and po stop recov ery from anesthesia were done on water-circulating heat ing pads. Rectal temperatures were monitored routinely at preanesthesia, presurgery following anesthesia, surgi cal MCA-O, and IS-min intervals during recovery.
Tissue preparation, staining, and quantitation
At the designated time point following the initiation of MCA-O (1-24 h), the rats were decapitated and the brains quickly removed from the cranium.
Spectrin breakdown products. The brains were imme diately placed in a freshly prepared cold, slushy cry obuffer ( = -12°C) for 2 min, as described previously (Seubert et aI., 1988) . Six I-mm blocks of tissue were cut using an ice-cold brain matrix and analyzed biochemically for spectrin breakdown. (Alternate 2-mm blocks from the same tissue were harvested for histologic staining.) The ratio of intact spectrin to specific breakdown products has been shown to provide a reliable marker for calpain proteolytic activity (Siman et aI., 1985a (Siman et aI., ,b, 1989 Ivy et aI., 1988; Seubert et aI., 1989) because cal pain proteolysis of spectrin produces a stable, characteristic pattern of products (i.e., ISOto ISS-kDa doublet) easily detected via Western blots (see Fig. I ). Standard Western blots were prepared (Seubert et aI., 1987 (Seubert et aI., , 1988 (Seubert et aI., , 1989 and quan titation of the immunoreactive species was made using a laser scanning densitometer. The amount of reaction product in each band was summed using an integrator and expressed as a percentage of the total in that sample.
Infarct volume (TTC). A standard TTC staining method (as described by Bederson et aI., 1986) was employed to distinguish infarcted from normal tissue. Alternate TTC sections (see the previous section) were digitized for computer-assisted infarct quantitation under coded con ditions. Enlarged digitized color images of the caudal and rostral faces of six sections per brain were generated and the infarct area was determined by quantifying white, nonstained tissue. The volume of the infarct was calcu lated using a standard trapezoidal equation (Bartus et aI., 1994b) .
Cell morphology (cresyl violet). Following the TTC staining and digitization, the tissue was immersion-fixed at 4°C in 4% paraformaldehyde for 2-4 weeks. Twenty four hours prior to histological sectioning, the tissue was transferred to a 20% sucrose solution in 4% paraformal dehyde, and the TTC-stained 2-mm blocks were cut with a freezing sliding microtome in 40-fLm sections for cresyl violet staining. The cresyl violet-stained tissue was eval uated by light microscopy in two stages. In the first, a SUbjective determination of the striatum and neocortex was made by two independent microscopists, using all the sections that comprised the areas normally encompassed by the infarct. In the second, at least two representative areas, SO,OOO fLm2 each) within the infarct were selected for coded quantitation of changes in cell number and size.
For blinded quantification of the number and size of neurons, a representative section that consistently con tained the infarcted area (based on TTC staining) was chosen separately for the striatum and neocortex. For the striatum, the dorsolateral area of the striatum, just medial to the external capsule was used. For the neocortex, lay- ers 2 through 4 of the dorsolateral parietal neocortex were evaluated. In both cases a 0.265 x O.IS-mm area was positioned under a microscope (400 x magnification) and digitized for image analysis. Both cell number and cell size were determined manually in each section. The ipsi lateral side of each animal was compared both to the con tralateral side of the I-h group and to normal (i.e., non ischemic) control sections. Four criteria were used to de fine an intact cell operationally. These were (a) size (>20 fLm2) , (b) shape (circular or pyramidal, not rod-like), (c) staining intensity, and (d) edges (distinct border). While all cells had to meet the first two criteria, some might not meet both criterion c and criterion d because staining intensity and edges sometimes vary due to tissue handling or photography. Overlapping cells were counted as more than one cell if the edges of each cell were distinct. A sample of 10 of the largest cells from the same area used to determine cell number was identified, and the edges of each cell were traced using a digitizing pad and image analysis to calculate cell area. Finally, for each animal, at least one additional neocortical and striatal section was randomly selected from the infarcted tissue and quanti tated in like manner to ascertain and reduce the proba bility of a sampling bias within the infarcted tissue for any animal.
Statistical analyses
Analyses of variance (ANOY As) were performed to confirm significant differences between groups. In situa tions where significant ANOY As were confirmed, indi vidual time points were compared against comparable control (i.e., nonischemia) values, using Student's t test, or Welch's (195 1) t test when it was necessary to control for differences in variability between groups.
RESULTS
Infarct volume (TTC stain)
Both striatal and neocortical TTC staining re vealed a significant change in infarct size over time [F(S, 33) = 23 .3, p < 0. 0001, and F(S, 33) = 16. 46, p < 0. 0001, respectively]. TTC staining in striatal tis sue over time exhibited a small, but reliable, infarct as early as 3 h postocclusion (t = 2. 3S, df = S, p < 0. 03 S), which continued to expand rapidly (lO-fold) through 6 and 12 h (t = 4. 73 , df = 4, p < O. OOS, and t = S. 98, df = 4, p < 0. 002, respectively; see Fig. 2). TTC staining in neocortex revealed the emer gence of a small, but significant, infarct by 6 h postocclusion (t = 3.01, df = 4, p < 0. 02), with a sixfold expansion in infarct volume between 6 and 12 h postocclusion (t = 3.SS, df = S, p < 0. 0l) and further, more modest increases through 24 h post occlusion (t = S. 28, df = 6, p < 0. 001; Fig. 3 ). In separate analyses, the relationship between infarct volume, as defined by TTC staining versus both cresyl violet and hematoxylin and eosin staining, proved to be quite good in this model (r = 0. 926, n = 6, and r = 0. 999, n = 9, respectively; p<0. 001).
Cell quantitation (cresy1 violet staining)
The SUbjective evaluation of cresyl violet-stained slides from the infarcted tissue (using 40-f-Lm-thick sections) revealed that at I h postocclusion, subtle hypotrophy (i. e. , cell shrinkage) in both the stria tum and the neocortex and triangulation in the shape of the majority of neurons in the neocortex were clearly evident ( Figs. 4 and S) . These changes were sufficiently robust and consistent to permit the identification of boundaries for the majority of isch emic tissue under a relatively low magnification. However, no obvious loss of neurons was noted by this subjective evaluation at I h postocclusion (con trary to the blinded, quantitative analysis, below). At the 3-and 6-h time points, additional hypotrophy seemed apparent, especially in the striatum, which also exhibited clear evidence of cell loss at those time points. In the neocortex, a similar pattern was subjectively observed, but delayed in onset. More intense triangulation of neurons was also observed in the neocortex as time progressed.
Quantitation of the number and size of the neu rons in representative striatal and neocortical sec tions is shown in Table 1 , demonstrating decreases in striatal and neocortical cell size [F(S ,37) = 26. 1, p < 0. 0001, and F(S, 37) = IS.3, p < 0. 0001, respec- breakdown products and TTC-defined infarct size in the ipsilateral striatum. The asterisks de note the points in time at which significant calpain-induced spectrin breakdown and TTC defined necrosis occurred. For graphic pur poses, the mean background spectrin break down immunoreactivity (from non ischemic and control brains) was subtracted from each deter mination. The contralateral striatum exhibited baseline levels of breakdown products as well as zero infarct volume over all time points.
FIG. 3. Mean time-related changes in spectrin
breakdown products and TTC-defined infarct size in the neocortex. The asterisks denote the earliest points in time at which significant calpain-induced spectrin breakdown and TTC defined necrosis occurred. Scores represent means. For graphic purposes, the mean back ground spectrin breakdown immunoreactivity (from nonischemic and control brains) was sub tracted from each determination. The contralat eral neocortex exhibited baseline levels of breakdown products as well as zero infarct vol ume over all time points.
50 tively], as well as striatal and neocortical cell num ber [F(S, 37) = 11. S, p < 0. 0001, and F(S, 37) = 31. 9, p < 0. 0001, respectively]. More specifically, this quanti tat ion confirmed subjective impressions of early, robust hypotrophy of neurons, establishing a significant decrease in cell size in the striatum by 1 h (t = 6. 42, df = 11, p < 0. 0001), with continued decreases in cell size occurring over the next 11 h (t = I1.S3, df = 11, p < 0. 0001). Similarly, in the neocortex, a significant decrease in cell size was measured at 1 h postocclusion (t = 3.37, df = 11, p < 0. 007); more severe changes, by 6 h (t = 7. 21, df = 10, p < 0. 0001) and beyond. A modest, but reliable, decrease in striatal cell number was seen in the first hour post -occlusion (t = 2. 23 , p < O. OS), with continuing losses occurring up to 12 h, at which point barely five cells per field (S%) could be identified that had retained sufficient morphologic characteristics to be included. At 3 h postocclusion, roughly SO% of the cells still ap peared morphologically intact. In the neocortex, this pattern of cell loss was similar, but relatively delayed. Significant loss of neocortical cells was not seen at 1 h postocclusion (t = 1. 73, df = 12, p > 0. 10) but was observed at 3 h postocclusion (t = 6. 76, df = 12, p < 0. 0001). While even more severe losses continued over time, at 12 h postocclusion, 40% of the cells still appeared morphologically in tact. By 24 h postocclusion, cell degeneration in the neocortex was complete (see Table 1 ).
Spectrin breakdown
Proteolysis of spectrin by calpain exhibited clear changes over time post MCA-O in both the striatum [F(S, 4S) = 19. 26, p < 0. 0001] and neocortex [F(S,4S) = 2S. S9, p < 0. 0001]. In both instances, these changes closely mirrored but clearly preceded the emergence of a necrotic infarct (see Figs. 2 and  3) . In the striatum, a significant increase in spectrin breakdown products was observed at the earliest time point measured (i. e. , 1 h, t = 4. 41, df = 13 , p 
DISCUSSION
The timing and interrelationship of changes in the three end points measured here (neuronal morphol ogy, TTC-defined infarct volume, and calpain mediated spectrin breakdown) provide insight into the pathogenic cascade that follows MCA-O. The changes observed at 1 h postocclusion are most in teresting in this regard. Numerous investigators have reported that the effects occurring at this time point are not lethal, since reperfusion at 1 h pre vents the later (24 h) appearance of an infarct (Ka plan et al. , 1991; Knight et al. , 1991; Buchan et al. , 1992; Memezawa et al. , 1992; Minematsu et al. , 1992a,b) . In our hands, subjective microscopic ex amination of the I-h histologic sections revealed the rough outline of tissue that would become infarcted by 12 to 24 h postocclusion, especially in layers 3 and 4 of the neocortex, thus confirming previous descriptions of gross prenecrotic changes. While subjective evaluation of cytomorphologic changes within the infarcted tissue (using light microscopy) revealed clear evidence of hypotrophy (i. e. , shrink age) of cells in both striatum and neocortex, no ap parent reduction in cell number was detected. How ever, blind quantitative assessment of the tissue re vealed a significant (3 0%) reduction in cell counts in the striatum, with a trend toward a similar reduction (20%) in the neocortex. In both instances, the hy potrophy and cell loss became increasingly more severe over the next several hours, reaching asymp tote at 6 to 12 h postocclusion in the striatum and at While both the striatum and cortex showed significant (p < 0.0001) decreases in cell size at 1 h postocclusion, only the striatum exhibited significant cell loss at I h (p < 0.05; cortex, p > 0.10). At 3 h postocclusion. cell number in both brain regions was significantly reduced (p < 0.0001). See Results section for more specific statistical information.
12 to 24 h in the neocortex. Significant changes in cal pain-induced spectrin breakdown were noted within the first hour in both brain regions-well in advance of detectable infarct formation and highly correlated with changes in cell shape and size. In each instance and time point, the changes were greater in the striatum, relative to the neocortex. The changes we quantified at 3 h of ischemia are noteworthy [i. e. , the point in time at which others, using reperfusion methods (Kaplan et aI. , 1991; Buchan et aI. , 1992; Memezawa et aI. , 1992) and magnetic resonance imaging (Knight et aI., 1991; Minematsu et aI. , 1992a,b) in conjunction with a 24-h-postocclusion determination point, suggest that irreversible cell damage occurs]. We noted ad ditional increases in spectrin breakdown, additional cell hypotrophy, and evidence of substantial cell loss in the center of the affected tissue in both brain regions. Nevertheless, the loss of cells at this time point still represents less than half the total cells that eventually die by 24 h postocclusion (as long as the ongoing pathology is permitted to maintain its course), and hypotrophy continued to be the more salient phenomenon. While gross prenecrotic changes were seen within the first and third hour, significant necrosis (i. e. , non-TTC-stained tissue)
was not yet observed. Identifying the time point following ischemia at which substantial neuronal death occurs is an im portant issue in contemporary research on isch emia. Information regarding this point should pro-vide insight into the length or the period over which it is possible to alter the intraneuronal cascade so as to salvage a significant portion of the neurons oth erwise destined to die. The present results indicate that striatum and neocortex are likely to be different in this regard. For neocortex, cell loss was marginal at 1 h, slightly greater but statistically robust at 3 h, and little changed from 3 to 6 h; a large decrease in numbers then occurred between 6 and 12 h. It thus appears that the cortex contains a population of rel atively vulnerable cells that degenerate quickly 0-3 h) and a larger ischemia-resistant subgroup. Inter estingly, the size of the cortical infarct parallels these changes, i. e. , relatively small changes up to 6 h and then a dramatic increase between 6 and 12 h. These observations indicate that the majority of cortical neurons is intact and functioning (at least in terms of respiratory enzymes) for at least 6 h of focal ischemia; this suggests that the potential win dow of opportunity for therapeutic intervention is somewhat longer than might be assumed from reperfusion studies. To exploit this window, it will be necessary to identify the types of pathogenic changes that occur up to 6 h that lead to the massive changes following that time point. Probably rele vant to this, the mean size of neocortical neurons in the ischemic region, while changing only slightly if at all from 1 to 3 h, decreases significantly from 3 to 6 h. It is tempting to speculate that this hypotrophic effect sets the stage for the large-scale loss of cells and growth of the cortical infarct that occurs be-tween 6 and 12 h. If this were the case, then the essential question becomes one of whether the de gree of change seen in the 3-to 6-h interval pro duces lethal effects that cannot be reversed or if, instead, the pathogenetic sequence can still be ar rested at this stage. Importantly, others have re ported that the majority of tissue affected by the hypotrophy seen at 1 h is able to recover from this early-stage pathology (Kaplan et al. , 1991; Knight et al. , 1991; Buchan et al. , 1992; Memezawa et al. , 1992; Minematsu et al. , 1992a,b) . What is not known is when additional hypotrophic changes be gin to reflect irreversible neuronal damage. It is well documented that the intense somatic atrophy that occurs following transection of basal forebrain ax ons is not associated with obligatory cell death, since it is possible to rescue these neurons weeks later with administration of nerve growth factor (Ragg et al. , 1988 (Ragg et al. , , 1989 Vahlsing et al. , 1991) . While the pathologies associated with retrograde degeneration and ischemia are clearly different, the capacity for recovery of severely atrophied neurons in the former instance indicates that caution should be exercised when considering the fate of the more modestly hypotrophic neurons found 6 h after the onset of focal ischemia.
As noted, cell losses were evident in the striatum after only 1 h of focal ischemia; this effect contin ued such that intact neurons were virtually absent in the infarcted region by 6 h. Thus, the period of relative stability (1-6 h) found in the neocortex was not evident in the striatum. The increased sensitiv ity to ischemia seen in the striatum is similar to the findings of Clark et al. (1993 ) and is likely due to the fact that the striatum lacks non-MCA collaterals, obtaining its entire supply of blood from the lentic ulate striate branch of MCA (Rieke et al. , 1981; Coyle and Jokelainen, 1982) . The size of the infarct also grew more rapidly in the striatum, but as with the cortex, the most dramatic change occurred be tween 6 and 12 h. It appears, then, that while patho genetic events proceed more rapidly in the striatum, a large area of ischemic tissue contains metaboli cally active cells even after 6 h. Minimally, then, it can be concluded that potential targets for thera peutic intervention are present even after prolonged occlusion of the vascular system. Thus, the quanti tative data presented here demonstrate that some neuronal loss occurs with ischemic episodes shorter than commonly believed but that the duration of opportunity for beneficial intervention may none theless be longer.
The data from the present study are also sugges tive of an important role for cal pain-mediated pro teolysis in the neurodegenerative cascade following focal ischemia. While spectrin proteolysis is not the most sensitive protein marker for calpain activation (Johnson et al. , 1991) or the only pathway by which excitatory amino acid-induced cell death may occur (DiStasi et al. , 1991; Manev et al. , 1991) , it never theless does provide a convenient and reliable (al beit conservative) marker for determining at which point in time cal pain activation necessarily oc curred (Siman et al. , 1984; Siman and Card, 1988; Siman and Noszek, 1988; Seubert et al. , 1989) . The results of this study demonstrate that calpain activ ity and proteolysis occur relatively early in the ischemia-induced cascade, with significant in creases over baseline occurring well in advance of significant tissue necrosis, defined by both the de velopment of an infarct (as measured by TTC) and clear evidence of cell disintegration (determined histologically in the neocortex). In fact, increases in cal pain-induced spectrin breakdown products were most clearly associated with the early-stage cellular events involving changes in neuronal size and shape. Thus, one might reasonably hypothesize that calpain proteolysis may play an important role in the morphological changes we and others have re ported as early-stage events in the pathogenic cas cade-events that are antecedent and possibly pre requisite to cell death.
In conclusion, the current study demonstrates the clear existence of a time-related expansion in in farct volume (measured by TTC and conventional histologic staining) that takes several hours to reach its zenith. Moreover, while some evidence of cell loss was seen within the first hour of ischemia, the more salient changes were in cell shape and size and calpain-induced proteolysis. Contrary to conclu sions drawn from less quantitative studies, a signif icant number of neurons remain morphologically in tact several hours following the occlusion, raising the question of whether the window of opportunity for therapeutic intervention may conceivably be longer than has been suggested previously.
Finally, the present data further support an im portant role of calcium-activated calpain proteoly sis in the events preceding major histopathology in the brain. Independent support for an important role of cal pain in focal ischemia has recently come from studies reporting significant reductions in neo cortical infarct volume when relatively selective calpain inhibitors were administered (Bartus et al. , 1994a,b; Hong et al. , 1994) . One study, in particu lar, supports the potential advantages of cal pain in hibition via a 75% reduction in infarct volume when the inhibitor was administered several hours after the occlusion (Bartus et al. , 1994a) . Collectively, the pathogenetic and pharmacologic studies pub-Ii shed to date provide mutually corroborating sup port for the hypothesis that calpin-induced proteol ysis plays an important role in focal ischemia and that selective inhibitors of calpain may provide a novel and effective means of protecting the brain from ischemia-related neuronal death.
